View in EDS

Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
Authors: Kaya NA; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Tai D; Division of Medical Oncology, National Cancer Centre Singapore, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore., Lim X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lim JQ; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Lau MC; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Bioinformatics Institute (BII), Agency of Science Technology and Research, Singapore., Goh D; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Phua CZJ; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Wee FYT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Joseph CR; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lim JCT; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Neo ZW; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Ye J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Cheung L; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore., Lee J; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore., Loke KSH; Duke NUS Medical School, Singapore.; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore., Gogna A; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore., Yao F; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Lee MY; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore., Shuen TWH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Toh HC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Hilmer A; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Koln, Cologne, Germany., Chan YS; Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong Province, China., Lim TK; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Tam WL; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Yeong J; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore., Zhai W; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37586766
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kaya+NA%22">Kaya NA</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Tai+D%22">Tai D</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+X%22">Lim X</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JQ%22">Lim JQ</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Lau+MC%22">Lau MC</searchLink>; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Bioinformatics Institute (BII), Agency of Science Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Goh+D%22">Goh D</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Phua+CZJ%22">Phua CZJ</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Wee+FYT%22">Wee FYT</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Joseph+CR%22">Joseph CR</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Lim+JCT%22">Lim JCT</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Neo+ZW%22">Neo ZW</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Ye+J%22">Ye J</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Cheung+L%22">Cheung L</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore.; Duke NUS Medical School, Singapore.<br /><searchLink fieldCode="AU" term="%22Loke+KSH%22">Loke KSH</searchLink>; Duke NUS Medical School, Singapore.; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Gogna+A%22">Gogna A</searchLink>; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Yao+F%22">Yao F</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+MY%22">Lee MY</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.<br /><searchLink fieldCode="AU" term="%22Shuen+TWH%22">Shuen TWH</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Toh+HC%22">Toh HC</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Hilmer+A%22">Hilmer A</searchLink>; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Koln, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Chan+YS%22">Chan YS</searchLink>; Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, Guangdong Province, China.<br /><searchLink fieldCode="AU" term="%22Lim+TK%22">Lim TK</searchLink>; Department of Anatomical Pathology, Singapore General Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Tam+WL%22">Tam WL</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Choo+SP%22">Choo SP</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Yeong+J%22">Yeong J</searchLink>; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore.<br /><searchLink fieldCode="AU" term="%22Zhai+W%22">Zhai W</searchLink>; Genome Institute of Singapore (GIS), Agency for Science(A*STAR), Technology and Research, Singapore weiweizhai@ioz.ac.cn yeongps@imcb.a-star.edu.sg david.tai.w.m@singhealth.com.sg.; Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2023 Aug; Vol. 11 (8).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37586766
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2023-007106
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kaya NA
      – PersonEntity:
          Name:
            NameFull: Tai D
      – PersonEntity:
          Name:
            NameFull: Lim X
      – PersonEntity:
          Name:
            NameFull: Lim JQ
      – PersonEntity:
          Name:
            NameFull: Lau MC
      – PersonEntity:
          Name:
            NameFull: Goh D
      – PersonEntity:
          Name:
            NameFull: Phua CZJ
      – PersonEntity:
          Name:
            NameFull: Wee FYT
      – PersonEntity:
          Name:
            NameFull: Joseph CR
      – PersonEntity:
          Name:
            NameFull: Lim JCT
      – PersonEntity:
          Name:
            NameFull: Neo ZW
      – PersonEntity:
          Name:
            NameFull: Ye J
      – PersonEntity:
          Name:
            NameFull: Cheung L
      – PersonEntity:
          Name:
            NameFull: Lee J
      – PersonEntity:
          Name:
            NameFull: Loke KSH
      – PersonEntity:
          Name:
            NameFull: Gogna A
      – PersonEntity:
          Name:
            NameFull: Yao F
      – PersonEntity:
          Name:
            NameFull: Lee MY
      – PersonEntity:
          Name:
            NameFull: Shuen TWH
      – PersonEntity:
          Name:
            NameFull: Toh HC
      – PersonEntity:
          Name:
            NameFull: Hilmer A
      – PersonEntity:
          Name:
            NameFull: Chan YS
      – PersonEntity:
          Name:
            NameFull: Lim TK
      – PersonEntity:
          Name:
            NameFull: Tam WL
      – PersonEntity:
          Name:
            NameFull: Choo SP
      – PersonEntity:
          Name:
            NameFull: Yeong J
      – PersonEntity:
          Name:
            NameFull: Zhai W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1